Clinical trials
Active, not recruiting Phase 3 Nervous System Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| Taysha Gene Therapies, Inc. | 2 |
| Capricor Inc. | 1 |
| Emalex Biosciences Inc. | 1 |
| Neurogene Inc. | 1 |
| Sanofi | 1 |
| iECURE, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nervous System Diseases | 9 |
| Genetic Diseases, X-Linked | 5 |
| Brain Diseases | 4 |
| Central Nervous System Diseases | 4 |
| Neurodevelopmental Disorders | 4 |
| Genetic Diseases, Inborn | 3 |
| Intellectual Disability | 3 |
| Mental Disorders | 3 |
| Neurodegenerative Diseases | 3 |
| Neurologic Manifestations | 3 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.